I knew that law would become my passion on my first day at law school. I was sold especially with the medical law classes and pharmaceutical law in practice. What I enjoy most about these two fields is their connection to the protection of human health, the inevitable clash of patients' and doctors' rights with the progress of the pharmaceutical industry, and the wide range of legal areas I encounter. My other lifelong passion is sport - I like to recharge my batteries on the bike path, on the snowy slopes and in the gym.
alzbeta.pospisilova@havelpartners.czArticles by the author
CCTV cameras in the healthcare sector under scrutiny by the Office for Personal Data Protection: What does the new Recommendation entail, and how does it differ from the general Methodology?
On 10 August 2026, the Office for Personal Data Protection (“UOOU”) issued Recommendation No. 01/2026 on CCTV systems installed on healthcare providers’ premises. The Recommendation follows up on the UOOU’s general Methodology for the Design and Operation of CCTV systems, whilst taking into account
Healthcare Digitalisation Continues: What Does the Proposed Amendment to the Healthcare Digitalisation Act Entail?
The Ministry of Health has submitted a far-reaching amendment that would revise the Healthcare Digitalisation Act, the Medicinal Products Act, and the Health Services Act. The amendment represents the first stage of implementing the EU Regulation on the European Health Data Space (EHDS). In addition
Compensation claims for personal injury in cases of progressive diseases
From what point may a patient suffering from a progressive disease bring a claim for compensation for personal injury caused by vaccination with a defective vaccine? Is the expiry of the ten-year limitation period, regardless of whether the claimant’s medical condition has stabilised, compatible wit
Compliance with the SmPC and the Presentation of Non-Registration Studies in Advertising
Informing healthcare professionals about the latest findings from studies related to medicinal products is crucial for ensuring effective and safe patient care. Access to the most recent scientific knowledge allows physicians to better understand the effects and potential side effects of medications
Changes to the Czech public health insurance system: what you need to know in a nutshell
To tackle rising costs and other current needs in public healthcare, the Ministry of Health presented a bill in April to amend the Public Health Insurance Act. Intended to take effect on 1 January 2026, the amendment concerns the regulation of prices and reimbursement of medicinal products and medic
No more giving gifts with a pack of cigarettes. Aren’t you engaging in prohibited practices?
Have you noticed this novelty? Just a few months after the prohibition of the sale of heated tobacco, there has been further regulation. The legislative change, which was adopted quietly late last year during the House of Deputies' consideration of the consolidation package, affects all tobacco and
Contributed to articles
Recent Judgments Issued in Relation to Medical Records
Can medical records also include a subjective assessment of the patient's behaviour? Is the healthcare provider obliged to provide the patient with a copy of his medical records without charging for the costs incurred? In today's post, we will present two judgments dealing with these issues. Their f
Amendment to the Act on Medicinal Products; new obligations to ensure availability of medicinal products
An amendment to the Act on Medicinal Products entered into effect as of 1 January 2024, imposing numerous new obligations on marketing authorisation holders, distributors and pharmacies, and expanding the existing powers of administrative authorities. The changes are primarily aimed at ensuring the